State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, China.
Department of Gynecology, Chongqing Haifu Hospital, Chongqing, China.
Int J Hyperthermia. 2024;41(1):2390124. doi: 10.1080/02656736.2024.2390124. Epub 2024 Aug 19.
To investigate all pregnancies and analyze the factors influencing pregnancy outcomes in patients with adenomyosis after high intensity focused ultrasound (HIFU).
A total of 231 patients with adenomyosis who completed HIFU and wished to conceive were enrolled. The symptom improvement and information of pregnancy were recorded during the follow-up period. Factors influencing pregnancy outcomes were analyzed using multivariate regression analysis and survival analysis.
After HIFU, 100 of 231 (43.3%) patients became pregnant within 96 months, including 77 (77/194, 39.7%) in natural and 23 (23/37, 62.2%) fertilization and embryo transfer (IVF-ET) pregnancies following gonadotropin-releasing hormone agonist (GnRHa). Among the 108 (46.8%, 108/231) infertile patients (defined as the failure to achieve pregnancy after 12 months of regular unprotected sexual intercourse, 40 primary infertility and 68 secondary infertility), 31 (28.7%) became pregnant. At the end of the follow-up, 70 successfully delivered 71 healthy babies. No uterine rupture occurred during pregnancy and delivery. Patients with pelvic adhesion and infertility history had a lower pregnancy chance than that of patients without pelvic adhesion and infertility history (OR < 1, < 0.05). Patients with small adenomyotic lesion volume had a greater pregnancy chance than that of patients with large lesion volume (OR < 1, < 0.05). IVF-ET following GnRHa had a better pregnancy chance ( < 0.05).
HIFU seems to have a beneficial effect on fertility of patients with adenomyosis. Pelvic adhesion, infertility history, and large adenomyotic lesion volume have adverse effects on pregnancy, but IVF-ET following GnRHa after HIFU could increase the pregnancy chance.
探讨高强度聚焦超声(HIFU)治疗子宫腺肌病后妊娠的相关因素。
回顾性分析 231 例 HIFU 治疗后有生育要求的子宫腺肌病患者的临床资料,随访并记录患者的症状改善及妊娠情况。采用多因素回归分析及生存分析方法分析影响妊娠结局的因素。
HIFU 治疗后 96 个月内,231 例患者中有 100 例(43.3%)妊娠,其中自然妊娠 77 例(77/194,39.7%),促性腺激素释放激素激动剂(GnRHa)促排卵后行体外受精-胚胎移植(IVF-ET)23 例(23/37,62.2%)。108 例(46.8%,108/231)不孕患者(12 个月未避孕未孕定义为不孕,其中原发不孕 40 例,继发不孕 68 例)中有 31 例(28.7%)妊娠。随访结束时,70 例患者成功分娩 71 例健康婴儿。妊娠及分娩过程中无子宫破裂发生。与无盆腔粘连及不孕史患者相比,有盆腔粘连及不孕史患者妊娠机会降低(OR<1, <0.05);与病灶体积大的患者相比,病灶体积小的患者妊娠机会增加(OR<1, <0.05);GnRHa 促排卵后行 IVF-ET 妊娠机会增加( <0.05)。
HIFU 治疗可能改善子宫腺肌病患者的生育能力。盆腔粘连、不孕史及病灶体积大对妊娠有不利影响,HIFU 后 GnRHa 促排卵行 IVF-ET 可增加妊娠机会。